← All organizations

Oxford BioMedica

For profitWebsite ↗

Also known as: Oxford BioMedica | Oxford Biomedical Technologies, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 17, 2018

Timeline

1990s

Jun 1, 1995
Oxford BioMedica— Founded

Drugs by trial phase (10 distinct, 14 trials)

Phase 3 (1 own, 0 via acquisition)

modified vaccinia ankara-5t4 vaccine

Phase 2 (8 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

retinostat

Indications

Studied for

Recent trials (14)

NCT03720418CollaboratorPhase 1/Phase 2Oct 17, 2018
NCT01556841CollaboratorPhase 2Nov 1, 2013
NCT01678872Lead sponsorPhase 1Aug 1, 2012
NCT01856439Lead sponsorPhase 1/Phase 2May 1, 2011
NCT01301443Lead sponsorPhase 1Feb 1, 2011
NCT01194960Lead sponsorPhase 2Aug 1, 2010
NCT00627588Lead sponsorPhase 1/Phase 2Jan 1, 2008
NCT00521274CollaboratorPhase 2Aug 1, 2007
NCT00397345Lead sponsorPhase 3Sep 1, 2006
NCT00448409CollaboratorPhase 2May 1, 2006
NCT00445523CollaboratorPhase 2May 1, 2006
NCT00325507Lead sponsorPhase 2Nov 1, 2005
NCT00083941Lead sponsorPhase 2Aug 1, 2004
NCT00259844CollaboratorPhase 2Jun 1, 2004

Details

Founded: Oxford, GB Jun 1, 1995
Last known activity: Oct 17, 2018